Therapeutic advantage of teriparatide in very elderly patients with proximal femoral fractures: a functional and BMD analysis

Table 2 Function score improvement of patients receiving different anti-osteoporotic medications after surgery for fracture (n = 126)

Item	Medication	N	Postop 3 months	Postop 24 months	Diff	Between-Group p-value	Within-Group p-value
VAS	Forteo	68	7.3 ± 0.9	2.8 ± 0.7	-4.4 ± 1.2	0.020*	< 0.001*
VAS	Prolia	58	7.2 ± 0.9	4.2 ± 0.9	-3.1 ± 1.1	0.020*	< 0.001*
Barthel scale	Forteo	68	33.1 ± 9.9	80.3 ± 12.6	46.2 ± 7.5	< 0.001*	< 0.001*
Barthel scale	Prolia	58	38.8 ± 1.2	69.0 ± 1.1	31.2 ± 6.6	< 0.001*	< 0.001*
BMD Femur	Forteo	68	-3.0 ± 0.6	-2.3 ± 0.6	0.7 ± 0.5	0.002*	< 0.001*
BMD Femur	Prolia	58	-3.1 ± 0.9	-2.6 ± 0.7	0.5 ± 0.7	0.002*	< 0.001*
BMD L1-4	Forteo	68	-3.1 ± 0.9	-2.1 ± 1.3	0.9 ± 0.8	0.003*	< 0.001*
BMD L1-4	Prolia	58	-3.2 ± 1.4	-2.6 ± 1.3	0.6 ± 0.7	0.003*	< 0.001*

Data are presented as n or mean ± standard deviation. *p-value < 0.05 was considered statistically significant after test. VAS visual analogue scale, BMD bone mineral density

ISSN: 1471-2474